Xenium In Situ platform allows for simultaneous expressions analysis of more than 5000 target genes at subcellular resolution. This technology combines single-molecule RNA hybridization with sophisticated optical technologies to enable precise detection and analysis of over 5,000 target genes within individual tissue sections. It is compatible with fresh frozen (OCT embedded) and FFPE tissues, providing an unmatched microscopic perspective for applications in tumor biology, neuroscience, immunology, and beyond.




